Creative Planning
CORV

Creative Planning’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Creative Planning’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-120
Closed -$1K – 4642
2015
Q4 		$1K Hold
120
– – ﹤0.01% 4298
2015
Q3 		$1K Buy
+120
New +$1.1K ﹤0.01% 4199
2015
Q2 		– Sell
-120
Closed -$1K – 3463
2015
Q1 		$1K Hold
120
– – ﹤0.01% 4106
2014
Q4 		$1K Hold
120
– – ﹤0.01% 4043
2014
Q3 		$1K Sell
120
-400
-77% -$2.91K ﹤0.01% 3902
2014
Q2 		$4K Buy
520
+400
+333% +$3.02K ﹤0.01% 3344
2014
Q1 		$1K Hold
120
– – ﹤0.01% 3550
2013
Q4 		$1K Hold
120
– – ﹤0.01% 3251
2013
Q3 		$0 Hold
120
– – ﹤0.01% 3408
2013
Q2 		$0 Buy
+120
New +$241 ﹤0.01% 3142

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Creative Planning's CORV Position: Q1 2016 in Review

Creative Planning sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2016, closing a stake of 120 shares — an estimated $1K sold.

Creative Planning first reported a position in CORV in Q2 2013 and held it in 10 quarters. The position peaked at $4K in Q2 2014. 26 funds tracked by Wall St. Rank hold CORV as of Q1 2016.

  • Creative Planning reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2016 after selling out during the quarter.
  • Creative Planning sold 120 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2016, an estimated $1K.
  • Creative Planning first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2013 and held it in 10 quarters.
  • Creative Planning's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $4K in Q2 2014.
  • 26 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2016.

Based on Creative Planning's 13F filing for Q1 2016, filed 8 Apr 2016.